CCEP is a high-quality cash compounder with exclusive Coca-Cola franchises, Southeast Asian growth optionality and a probability-weighted 5-year value of $111.89 versus $102.88 today.
Coca-Cola Europacific Partners PLC (CCEP) is the premier independent bottling partner within the global Coca-Cola system [cite: 1]. The company operates by purchasing advanced beverage concentrates and syrups from major trademark owners—primarily The Coca-Cola Company (TCCC) and Monster Beverage Corporation—and executing the localized manufacturing, packaging, cold-drink placement, and multi-channel distribution across its territories [cite: 1, 2, 3]. Its expansive geography spans 31 distinct markets in Western Europe, Australia, New Zealand, the Pacific Islands, and Southeast Asia, serving a total addressable consumer population of over 600 million [cite: 4].
To represent its geographic performance and commercial segments effectively, a structural breakdown of the business is presented below:
| Geographic Segment | Key Territories Included | Volume Share Change (FY2025) | H1 2026 Revenue (€ Millions) | H1 2026 Vol. (Million Unit Cases) | Segment Characteristics & Channel Exposure |
|---|---|---|---|---|---|
| Europe | Great Britain, Germany, France, Iberia, Benelux, Nordics [cite: 5, 6, 7] | -10 basis points [cite: 6, 8] | €7,911 [cite: 2, 9] | 1,308 [cite: 2, 9] | Highly consolidated retail market; significant Home channel focus; premium pricing power in Great Britain and France [cite: 2, 5, 6]. |
| Australia, Pacific & Southeast Asia (APS) | Australia, New Zealand, Papua New Guinea, Indonesia, Philippines [cite: 2, 7, 10] | +90 basis points [cite: 6, 8] | €2,813 [cite: 2, 9] | 733 [cite: 2, 9] | High growth potential; fragmented retail networks; significant expansion in the Philippines and Indonesia [cite: 10, 11]. |
The products manufactured and distributed by CCEP are categorised into sparkling beverages, energy drinks, hydration/sports solutions, and still ready-to-drink options such as tea and coffee [cite: 2, 12]. Rather than standard generic beverages, the portfolio consists of globally recognised, high-equity brand trademarks, including Coca-Cola, Fanta, Sprite, Powerade, Fuze Tea, and Monster Energy [cite: 2, 13]. These products are packaged across various formats—such as single-serve glass bottles for on-premise channels and large multi-can packs for grocery chains [cite: 2, 6].
CCEP distributes its products to two main customer types: the Home channel and the Away-from-Home (AFH) channel [cite: 6, 9]. The Home channel primarily serves large-scale supermarket chains, discount retailers, and e-commerce platforms where consumer focus is directed at convenience and bulk values [cite: 6, 8, 14]. The Away-from-Home channel encompasses immediate-consumption settings such as restaurants, hotels, quick-service cafes, and leisure venues [cite: 6, 9].
Customers select CCEP as their anchor beverage supplier due to its category captaincy and operational integration [cite: 8, 15]. For large retailers, CCEP provides data-driven category management and promotional optimization, which drives foot traffic and maximizes shelf-space profitability [cite: 6, 10, 15]. In the fragmented Away-from-Home channel, customers choose CCEP because of its direct supply-chain reliability, extensive localized distribution network, and proprietary fleet of smart cold-drink coolers [cite: 1, 10].
CCEP's top-line performance is driven by a combination of physical unit case volume, headline pricing actions, and promotional and package mix optimization [cite: 6, 9]. The relationship between CCEP and its raw concentrate suppliers—specifically The Coca-Cola Company—operates on an incidence pricing model [cite: 16]. Under this structural mechanism, the cost of beverage concentrate is calculated as a direct percentage of CCEP's realized net revenue per unit case [cite: 16]. This means that when CCEP successfully implements price increases to offset inflation, the brand owner shares in the upside, while CCEP must rely on cost efficiency and premium package mix to expand its operational margins [cite: 8, 10, 16].
CCEP's growth is driven by its strategic focus on emerging markets in Southeast Asia [cite: 10]. In the Philippines, the integration of CCBPI has progressed ahead of expectations, with its EBIT margin approaching the group's 10% target [cite: 11]. To support this volume runway and reduce transportation bottlenecks, CCEP is building a new production facility scheduled to open in 2027 [cite: 11]. In Indonesia, CCEP is executing a route-to-market restructuring and portfolio adjustment to recover sparkling beverage volumes and drive immediate-consumption execution through targeted single-serve offerings [cite: 10, 11]. On a global level, CCEP continues to deploy its proprietary smart-cooler fleet, adding more than 80,000 advanced coolers in the first half of 2026 alone [cite: 10]. These coolers act as high-efficiency, exclusive sales points that secure premium shelf-space in retail environments and restrict competitors from accessing on-premise demand [cite: 2, 10].
CCEP's economic moat is built on exclusive franchise territories, brand equity, high switching costs, and capital-intensive distribution networks [cite: 1, 17]. Under its long-term bottling agreements, CCEP holds exclusive territorial locks, shielding it from direct competition within its geographic regions [cite: 1]. This structure allows CCEP to benefit from TCCC's multi-billion dollar marketing campaigns and brand equity without bearing the cost of product R&D or IP creation [cite: 1, 18]. At the retail level, switching costs are high because trademark Coca-Cola and Monster Energy are essential traffic drivers [cite: 2, 10]; retailers cannot drop CCEP's core brands without experiencing a decline in store traffic [cite: 2, 10]. Furthermore, the physical network of production plants, localized warehouses, and proprietary cooler placement creates a massive barrier to entry [cite: 5, 10]. Any competitor attempting to displace CCEP would need to duplicate this capital-intensive supply chain and logistics network [cite: 1, 5].
The total addressable consumer market across CCEP's 31 active territories stands at more than 600 million people [cite: 4]. While the European NARTD market is highly mature, CCEP captures incremental value by shifting its product mix toward premium formulations, natural mineral waters, and energy drinks [cite: 2, 8]. In contrast, Southeast Asian markets present structural volume opportunities, with low per-capita beverage consumption and expanding urban middle classes [cite: 10].
CCEP operates in a consolidated market, primarily competing against other large-scale beverage bottlers, private-label carbonated soft drinks, and local specialty brand owners [cite: 6, 9, 19].
| Competitor Category | Core Competitors | Strategic Positioning vs. Competitor | CCEP Market Share Status |
|---|---|---|---|
| PepsiCo Bottling Groups | Regional independent Pepsi bottlers, major grocery private brands [cite: 6, 9]. | CCEP leverages the stronger brand equity of Trademark Coca-Cola vs. Pepsi, alongside its localized scale and category management capabilities [cite: 6, 8]. | Gaining Ground: Total NARTD value share expanded by +20 basis points in FY2025, driven by a +90 basis point gain in the APS region [cite: 6, 8]. |
| Suntory Distributors | Regional soft drink and alcohol distributors [cite: 8, 9]. | CCEP has focused its portfolio on core high-margin non-alcoholic brands, exiting lower-margin third-party contracts (such as the Suntory alcohol agreements in Australia and New Zealand) [cite: 2, 8, 9]. | Holding Ground: Short-term revenue headwind of ~0.5% from exiting the contract was offset by improved brand and mix margin [cite: 8, 16]. |
| Private Label Options | Store-brand colas and carbonated mixers [cite: 6]. | CCEP utilizes revenue growth management, offering premium packaging and tailored price-points to target value-conscious shoppers during economic downturns [cite: 6, 9]. | Holding Ground: Strong consumer pull for premium brand equity has limited private-label erosion in core categories [cite: 6, 9]. |
CCEP announced its interim financial results for the six months ended July 3, 2026, on August 4, 2026 [cite: 9, 10]. The company delivered solid top- and bottom-line growth during the first half of 2026 [cite: 9, 10]. Total reported revenue reached €10.724 billion, an increase of 4.4% on a reported basis and 6.1% on a comparable, foreign-exchange-neutral (FXN) basis compared to H1 2025 [cite: 9, 10]. This performance was driven by reported volumes of 2,041 million unit cases, up 5.6% [cite: 9]. Adjusting for six additional consumption days relative to the prior period, group volumes grew by 2.2% on a days-adjusted basis [cite: 9, 10]. H1 2026 reported revenues were in line with consensus expectations, while comparable diluted EPS of €2.20 (up 10.6% FXN) beat analyst estimates by 2.8% [cite: 9, 20].
Management reaffirmed its full-year 2026 outlook, projecting comparable FX-neutral revenue growth of 3% to 4%, operating profit growth of approximately 7%, and comparable cost of sales per unit case growth of approximately 1.5% [cite: 8, 10]. Chief Executive Officer Damian Gammell noted that while H1 2026 performance was strong, investors should prepare for several operational headwinds in the second half of the year [cite: 2, 10]. Specifically, H2 2026 will have six fewer trading days compared to H2 2025, which is expected to impact reported volumes and revenues [cite: 10]. Additionally, operating and concentrate costs are expected to be higher in the back half of the year [cite: 10]. Under current spot rates, foreign exchange represents a projected headwind of 40 basis points to full-year revenue and 10 basis points to operating profit [cite: 11].
CCEP's stock price reacted with caution to the H1 results, falling 2.46% to $105.53 USD in premarket trading on August 4, 2026, as investors focused on the cautious outlook for the second half of the year [cite: 10]. On September 4, 2026, JP Morgan reinstated coverage with an "Underweight" rating and a $92.00 USD price target, arguing that premium valuations may be difficult to sustain if volume growth moderates into 2027 [cite: 21]. Conversely, the consensus rating remains a Moderate Buy with an average price target of $108.44 USD [cite: 22].
| Financial Metric | H1 2025 Baseline | H1 2026 Reported | Change (Reported) | Change (FXN Comparable) |
|---|---|---|---|---|
| Volume (Million Unit Cases) | 1,932 [cite: 16] | 2,041 [cite: 2, 9] | +5.6% [cite: 2, 9] | +2.2% (Days-Adjusted) [cite: 9] |
| Revenue (€ Millions) | €10,274 [cite: 16] | €10,724 [cite: 2, 9] | +4.4% [cite: 2, 9] | +6.1% [cite: 2, 9] |
| Operating Profit (€ Millions) | €1,364 [cite: 16] | €1,458 [cite: 2, 9] | +6.9% [cite: 2, 9] | +8.1% (Comparable) [cite: 2, 9] |
| Comparable Free Cash Flow (€ Millions) | €425 [cite: 16] | €435 [cite: 9, 10] | +2.4% [cite: 9, 10] | N/A |
| Diluted EPS (€) | €1.99 [cite: 16, 20] | €2.17 [cite: 9, 20] | +9.1% [cite: 9, 20] | +10.6% (Comparable) [cite: 2, 9] |
To connect CCEP's valuation to its business model, investors should analyze its long-term financial trajectory [cite: 5, 8]. Over the five-year period from FY2021 to FY2025, revenues grew from €13,760 million to €20,901 million, representing a CAGR of approximately 11.0% [cite: 8, 23]. This performance was driven by strategic acquisitions, pricing actions, and category expansion into energy and sugar-free offerings [cite: 2, 15, 24].
| Fiscal Year | Total Revenue (€ Billions) | Gross Profit Margin | Reported Operating Profit (€ Billions) | Outstanding Share Count (Millions) | Comparable Free Cash Flow (€ Billions) |
|---|---|---|---|---|---|
| FY2021 | €13.76 [cite: 23] | 36.95% [cite: 23] | €1.48 (EBIT) [cite: 25] | 456.24 [cite: 23] | €1.40 [cite: 23] |
| FY2022 | €17.32 [cite: 23] | 35.94% [cite: 23] | €2.13 (EBIT) [cite: 25] | 456.96 [cite: 23] | €1.39 [cite: 23] |
| FY2023 | €18.30 [cite: 23] | 36.72% [cite: 23] | €2.34 [cite: 23, 26] | 459.20 [cite: 23] | €1.73 [cite: 26] |
| FY2024 | €20.44 [cite: 23] | 35.28% [cite: 23] | €2.13 [cite: 15, 23] | 460.85 [cite: 23] | €1.82 [cite: 15] |
| FY2025 | €20.90 [cite: 8, 23] | 35.60% [cite: 23] | €2.79 [cite: 12, 23] | 453.45 [cite: 23] | €1.84 [cite: 8] |
CCEP is subject to several structural and macroeconomic risks that could impact its long-term financial performance [cite: 6, 11]. High inflation in commodities—such as aluminum, sugar, and PET plastics—directly increases the cost of sales per unit case [cite: 16, 17]. While CCEP implements headline price increases to pass through these inflationary pressures, aggressive pricing can lead to volume erosion or prompt consumers to switch to lower-priced private-label alternatives, particularly during economic downturns [cite: 6, 11].
Regulatory interventions present an ongoing challenge for CCEP's operations in Western Europe [cite: 6]. The implementation of sugary beverage taxes—such as the recent tax increases in France—can create headwinds for sparkling volumes and require CCEP to adjust its product portfolio toward low-sugar or reformulating existing variants [cite: 6]. Additionally, the introduction of environmental regulations, such as deposit-return schemes (DRS) across the European Union, can increase compliance and packaging logistics costs [cite: 17].
In the APS region, expansion into high-growth markets like the Philippines and Indonesia offers volume opportunities but introduces higher operational and macroeconomic risks [cite: 10]. CCEP is currently executing several capital projects, including a new production facility in the Philippines scheduled to open in 2027 [cite: 11]. Any construction delays or operational issues would directly affect near-term returns on invested capital (ROIC) [cite: 8]. Additionally, emerging market sales are exposed to currency translation risks and volatile local inflation, which can impact the profitability of these growth engines [cite: 8, 11].
To provide a systematic framework for analyzing these risks, the table below categorizes the core risks, their early warning indicators, and their long-term impact on CCEP’s business model:
| Risk Category | Core Operational Mechanism | Early Warning Indicators | Long-Term Thesis Impact |
|---|---|---|---|
| Macroeconomic & Commodity Risk | Inflation in input costs (aluminum, PET plastic, sugar, and energy) directly impacts CCEP's cost of sales per unit case [cite: 16, 17]. | A rise in commodity spot prices or cost of sales per unit case expanding beyond guided levels [cite: 8, 10]. | Sustained gross margin contraction if inflation cannot be offset by pricing actions [cite: 8, 16]. |
| Regulatory & Sugar Tax Risk | Governments expand sugary drink taxes or impose packaging restrictions (e.g., EU deposit-return schemes) [cite: 6, 17]. | New legislative proposals for sugar taxes or environmental packaging penalties in core European markets [cite: 6, 17]. | A permanent reduction in carbonated soft drink volumes, forcing expensive product reformulations [cite: 6]. |
| Franchise Dependence Risk | CCEP depends on TCCC for its exclusive bottling rights, concentrate supply, and raw concentrate pricing [cite: 1]. | An upward adjustment in TCCC's concentrate pricing formulas or changes in joint marketing allocations [cite: 1, 27]. | Margin compression if TCCC adjusts concentrate prices to capture a larger share of the system's economics [cite: 1]. |
| Emerging Market Execution Risk | Delays or cost overruns in construction projects (e.g., the 2027 Philippines facility) impact volume scaling [cite: 11]. | Construction delays or localized supply-chain disruptions in Southeast Asia [cite: 11]. | A reduction in CCEP's ROIC and lower-than-expected growth contribution from Southeast Asia [cite: 8, 10]. |
| Currency Translation Risk | Revenue generated in non-Euro currencies (GBP, AUD, PHP, IDR) is exposed to translational FX fluctuations [cite: 8, 9]. | Increased volatility in emerging market exchange rates or a sustained strengthening of the Euro [cite: 8, 9]. | Reported earnings volatility and translation headwinds that compress reported growth metrics [cite: 11]. |
This 5-year scenario model evaluates CCEP's performance from the end of fiscal year 2025 through fiscal year 2030 (Year 5). All share prices and financial values are represented in USD, using a constant exchange rate of 1.10 USD per EUR where currency translation is required [cite: 1, 10, 28]. The starting share price is set at $102.88 USD (as of September 2026), with an outstanding starting share count of 441.14 million ordinary shares [cite: 1, 21].
The scenario models utilize the following assumptions:
The probability-weighted target price is calculated as follows:
$\text{Weighted Price Target} = (\$156.62 \times 0.20) + (\$113.85 \times 0.60) + (\$61.29 \times 0.20) = \$111.89\text{ USD}$
This indicates that at its current price of $102.88 USD, the stock is currently valued at a discount to its probability-weighted long-term intrinsic value [cite: 21].
| Scenario | Revenue / Key Metric in Year 5 (USD) | Margin / Earnings Assumption | Valuation Multiple Assumption (P/E) | Current Share Price (USD) | Implied Future Share Price (USD) | 5-Year Total Return | Annualized Return | Probability |
|---|---|---|---|---|---|---|---|---|
| High Case | $28.50 Billion [cite: 20] | 10.2% Net Margin / $7.46 EPS [cite: 20, 29] | 21.0x [cite: 1] | $102.88 [cite: 21] | $156.62 | 67.8% [cite: 29, 31] | 10.9% | 20% |
| Base Case | $27.31 Billion [cite: 20] | 9.5% Net Margin / $6.33 EPS [cite: 19] | 18.0x [cite: 20] | $102.88 [cite: 21] | $113.85 | 21.8% [cite: 29, 31] | 4.0% | 60% |
| Low Case | $24.16 Billion [cite: 20] | 8.0% Net Margin / $4.38 EPS [cite: 6, 19] | 14.0x | $102.88 [cite: 21] | $61.29 | -32.2% [cite: 31] | -7.5% | 20% |
STABLE CASH COMPOUNDER
Note to reader: This scorecard is for informational purposes only and does not constitute a recommendation or financial advice.
Blended Quality Score: 8.3 / 10
ROBUST DEFENSIVE STAPLE
Note to reader: This section is for informational purposes only and does not constitute a recommendation or financial advice.
CCEP represents a highly cash-generative consumer defensive business with solid market positioning [cite: 8, 10]. The mature European segment provides stable cash flow, supported by brand equity and pricing power to offset cost inflation [cite: 5, 6, 8]. This baseline profitability supports consistent dividend payouts and capital returns to shareholders [cite: 8, 33]. Meanwhile, the expansion into emerging markets in Southeast Asia (specifically the Philippines and Indonesia) offers a long-term volume runway to complement its mature geographic segments [cite: 10]. Near-term structural catalysts include the construction of the new production facility in the Philippines in 2027 and the continuous execution of the €1 billion share buyback program [cite: 8, 11]. While the company faces risks from raw commodity inflation, regulatory sugar taxes, and currency translational headwinds, its competitive advantages and exclusive franchise rights provide solid downside support [cite: 1, 6, 8].
STABLE CAPITAL REINVESTOR
CCEP's short-term price action exhibits a neutral consolidation pattern [cite: 21]. The stock is trading at $102.88 USD, remaining above its long-term 200-day simple moving average of $96.12 USD (or $100.45 USD depending on the market venue) [cite: 22, 35]. The 50-day moving average is $102.70 USD [cite: 35], showing a consolidation phase after pulling back from its 52-week high of $113.67 USD [cite: 10, 21]. Short-term support is established near $103.67 USD, with immediate resistance around $105.69 USD [cite: 21]. The stock's recent pullback was driven by institutional rotation out of defensive consumer staples and broker downgrades, but its ongoing €1 billion share buyback program provides near-term downside support [cite: 21].
CONSOLIDATING UPTREND TREND
View Coca-Cola Europacific Partners PLC (CCEP) stock page
Loading the interactive version of this report…